Opportunity Information: Apply for RFA AG 20 003
The National Institutes of Health (NIH), through the National Institute on Aging (NIA), issued this funding opportunity announcement (RFA-AG-20-003) to support a Demography and Economics of Aging and Alzheimer’s Disease/Alzheimer’s Disease Related Dementias (AD/ADRD) Coordinating Center (CC) using the R24 grant mechanism (clinical trials not allowed). The core idea is to fund a single coordinating hub that connects and supports two related networks of NIA-funded research centers: (1) the traditional Centers on the Demography and Economics of Aging (D and E Centers) and (2) Centers on the Demography and Economics of AD/ADRD (D and E Centers on AD/ADRD). Rather than being another stand-alone research center, the CC is meant to strengthen the overall program by improving coordination, communication, shared infrastructure, and the visibility and usability of what the centers produce.
The broader D and E Center programs are designed to seed new lines of research and expand the community of researchers working at the intersection of population aging, economics, and dementia-related topics. On the general aging side, that includes research on demographic change, labor and retirement, household finances, intergenerational transfers, health and disability trends, and the economic consequences of longer lives. On the AD/ADRD side, it extends to demography, economics, and health services research that is directly relevant to Alzheimer’s and related dementias, such as patterns of diagnosis and care, caregiver impacts, costs and financing of long-term services and supports, disparities, and how health systems and policies shape outcomes for individuals and families. The centers pursue these goals through theme-based research and shared infrastructure activities that help launch new projects, bring in new investigators, and make data, methods, and findings more accessible.
The Coordinating Center’s responsibilities are explicitly program-facing and network-facing. It is expected to work collaboratively with all participating center sites to keep an active multi-center website that serves as a central public home for the program. Through that website and related outreach, the CC disseminates research advances, ongoing activities, and shared resources to multiple audiences, including researchers, policymakers, and other stakeholders who use evidence on aging and dementia to inform decisions. A second major duty is building and maintaining a centralized tracking database that captures progress, outputs, and outcomes from both the individual centers and the CC itself. This database is intended to support consistent annual reporting back to each center and to NIA program staff, and it also creates a structured record that NIA can use for future program evaluation.
The FOA also emphasizes the CC’s convening and community-building role. The CC is responsible for organizing an annual in-person meeting, which functions as a key point of connection across the two center programs and an opportunity to share results, align priorities, and spark collaborations. Beyond the annual meeting, the CC is expected to foster regular communication and collaborative activities within and across the D and E Center networks and to connect with other NIA research centers when relevant. In practice, this means the CC serves as the main point-of-contact for the overall D and E Centers program for NIA staff, other NIA centers, and the broader scientific community, helping inquiries find the right people and helping the network function as a coherent program rather than a set of disconnected awards.
Eligibility is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (other than federally recognized governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than higher education institutions); for-profit organizations (other than small businesses); small businesses; and other entities. The FOA also calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, the announcement clearly restricts foreign involvement. Non-domestic (non-U.S.) entities (both foreign organizations and foreign institutions) are not eligible to apply. Non-domestic components of U.S. organizations are not eligible to apply, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. The opportunity is categorized as discretionary funding, uses the grant instrument, and falls under the health funding activity category with CFDA number 93.866. The original closing date listed for applications was 2019-06-03, and the FOA was created on 2018-10-30. The award ceiling and expected number of awards are not specified in the provided source details.Apply for RFA AG 20 003
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Demography and Economics of Aging and AD-ADRD Coordinating Center (R24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2018-10-30.
- Applicants must submit their applications by 2019-06-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required)
Previous opportunity: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 20 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 20 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional) Apply for RFA AG 20 001 Funding Number: RFA AG 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $545,000 |
| Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional) Apply for RFA AG 20 002 Funding Number: RFA AG 20 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed) Apply for PA 19 043 Funding Number: PA 19 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) Apply for PA 19 046 Funding Number: PA 19 046 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional) Apply for PA 19 047 Funding Number: PA 19 047 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) Apply for PAR 19 048 Funding Number: PAR 19 048 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed) Apply for PA 19 049 Funding Number: PA 19 049 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Sustainable Access for Expanded Voluntary Medical Male circumcision (VMMC) Services (SAFE) Apply for SOURCES SOUGHT NOTICE 2018 Funding Number: SOURCES SOUGHT NOTICE 2018 Agency: Tanzania USAID-Dar es Salaam Category: Health Funding Amount: Case Dependent |
| Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) Apply for RFA AG 20 004 Funding Number: RFA AG 20 004 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed) Apply for PAR 19 061 Funding Number: PAR 19 061 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) Apply for PA 19 067 Funding Number: PA 19 067 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 053 Funding Number: RFA AI 18 053 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) Apply for PA 19 066 Funding Number: PA 19 066 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) Apply for PA 19 068 Funding Number: PA 19 068 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed) Apply for RFA DE 19 008 Funding Number: RFA DE 19 008 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed) Apply for RFA DE 19 009 Funding Number: RFA DE 19 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional) Apply for RFA AA 19 005 Funding Number: RFA AA 19 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 19 070 Funding Number: PAR 19 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) Apply for PAR 19 071 Funding Number: PAR 19 071 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 18 057 Funding Number: RFA AI 18 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
